home > research channels > sectors > pharma


Latest News
22-Mar-2017 US Ban on Divi's Labs may Dent Profits by Up to 25%
20-Mar-2017 Daiichi's Ranbaxy Profits Outweigh Losses: Singhs
15-Mar-2017 Sun's Mohali Facility Out of FDA Cloud
10-Mar-2017 Cipla Can't Sell Copy of Novartis Drug Onbrez: HC
  more...
Latest Reports
Feb-17 Demonetization impact subsides but full recovery in IPM not clear
Feb-17 Q3 Review: Margin beat but core EBITDA weak
Feb-17 Biosimilar Opportunity For Indian Players
Feb-17 Speeding up FDA approvals, negative for generics; positive for CRAMS
  more...

Quarterly Summary (December Quarter)
Desc Current Previous Per.Chg
Sales 34147.0 32786.8 4.1
Otherincome 1138.4 774.1 47.1
Expense 27790.9 26555.4 4.7
RawMaterial 10251.1 10599.5 -3.3
StaffCost 5100.8 4572.3 11.6
ExciseDuty 201.8 86.3 133.8
OtherExp 9305.9 8433.0 10.4
Interest 942.6 985.3 -4.3
GrossProfit 7418.9 7016.1 5.7
Depreciation 1482.8 1405.7 5.5
Tax 1501.1 1253.1 19.8
NetProfit 4379.1 4324.8 1.3
Total.Comp 167 -- --
Source: ETIG Database

Sectoral Companies As on 28 Mar 2017
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 167603.10
Lupin 65775.54
Cipla 47783.28
Cadila Healt 46368.49
Dr.Reddy's 43686.58
Aurobindo Ph 39806.05
Piramal Entp 32137.44
Alkem Labora 26300.40
Glenmark Pha 24746.12
Torrent Phar 24448.06
GlaxoSmith.P 22886.79
Biocon 22734.00
Divi's Lab 16773.79
  click here for the complete list